Literature DB >> 30926278

Validation and implementation of the fifth-generation high sensitivity Troponin T (hs-TnT) assay at a large teaching county hospital. A laboratory-driven multi-speciality effort.

Ibrahim A Hashim1, Rebecca Vigen2, Fernabelle Fernandez3, Amy Yu3, Bryan Bertulfo3, Lorie Thibodeaux3, Sandeep R Das2, Deborah Diercks2, James A de Lemos2, Patricia Kutscher3.   

Abstract

We describe the validation and implementation of the new 5th generation high sensitivity Troponin T assay (Roche Diagnostics®). In addition to the assay improved sensitivity, the numerical values, reporting units, reference intervals, and critical limits are markedly different. We describe the use of clinical correlation as the basis for implementation and validation of the fifth-generation hs-TnT assay at a large teaching county hospital.
Copyright © 2019 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  5th generation hs-TnT; High sensitivity Troponin T; Implementation

Mesh：

Substances：

Year:  2019        PMID： 30926278     DOI： 10.1016/j.cca.2019.03.1630

Source DB:  PubMed          Journal:  Clin Chim Acta        ISSN： 0009-8981            Impact factor:   3.786


  2 in total

1.  Association of a Novel Protocol for Rapid Exclusion of Myocardial Infarction With Resource Use in a US Safety Net Hospital.

Authors:  Rebecca Vigen; Deborah B Diercks; Ibrahim A Hashim; Ambarish Pandey; Lin Zhong; Patricia Kutscher; Fernabelle Fernandez; Amy Yu; Bryan Bertulfo; Kyle Molberg; Jeffery C Metzger; Jose Soto; Dergham Alzubaidy; Lorie Thibodeaux; Jose A Joglar; Sandeep R Das; James A de Lemos
Journal:  JAMA Netw Open       Date:  2020-04-01

2.  Predictive ability of EuroSCORE II integrating cardiactroponin T in patients undergoing OPCABG.

Authors:  Xiang Li; Lingtong Shan; Mengwei Lv; Zhi Li; Chunyan Han; Ban Liu; Wen Ge; Yangyang Zhang
Journal:  BMC Cardiovasc Disord       Date:  2020-10-28       Impact factor: 2.298
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.